Journal
MICROCHIMICA ACTA
Volume 180, Issue 9-10, Pages 855-860Publisher
SPRINGER WIEN
DOI: 10.1007/s00604-013-0998-3
Keywords
Droplet microfluidics; Point-of-care diagnostics; Biosensor microsphere; Tetanus immunization status
Categories
Funding
- ECOR postdoctoral award
- Shriners Grant [85120-BOS]
Ask authors/readers for more resources
We have developed a sensitive, specific, rapid and low cost picoliter microsphere-based platform for bioanalyte detection and quantification. In this method, a biological sample, biosensing microspheres, and fluorescently labeled detection (secondary) antibodies are co-encapsulated to capture the analyte (here: human anti-tetanus immunoglobulin G) on the surface of the microsphere in microfluidic pL-sized droplets. The absorption of the analyte and detecting antibodies on the microsphere concentrate the fluorescent signal in correlation with analyte concentration. Using our platform and commercially available antibodies, we were able to quantify anti-tetanus antibodies in human serum. In comparison to standard bulk immunosorbent assays, the microfluidic droplet platform presented here reduces the reagent volume by four orders of magnitude, while fast reagent mixing reduces the detection time from hours to minutes. We consider this platform to be a major leap forward in the miniaturization of immunosorbent assays and to provide a rapid and low cost tool for global point-of-care.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available